Preclinical development of virus-like particle (VLP)-based immunotherapy against HDM allergy. Patniboon P, Thanasarnthungcharoen C, Chanasit S, Fievez L, et al. Allergy 2024 Oct 25. doi: 10.1111/all.16375.

Read + Share

Amedeo Smart

Independent Medical Education

Patniboon P, Thanasarnthungcharoen C, Chanasit S, Fievez L, et al. Preclinical development of virus-like particle (VLP)-based immunotherapy against HDM allergy. Allergy 2024 Oct 25. doi: 10.1111/all.16375.
PMID: 39450698